my own take for what it's worth, PR has a bunch of contacts and a good team, they are engaging actively with pharma with the two programs. I am lucky to have met him a couple of times and he is a very genuine and friendly guy.
my view on PAR is simply that it is in the phase 3 "valley of boredom". the share price has come down, but to new honest it peaked harder than I expected a few years ago at which point I sold.
have been continuing to follow the story and it's now getting to the point where I will be looking to start accumulating again ahead of MPS readouts / partnership. for OA for me personally it will be once the first stage is complete and the dosing figured out for stage 2. until then there is simply time to wait and people get bored hence a slowly declining share price.
at the end of the day results are king in biotech
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-263
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $71.79M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.5¢ | 19.5¢ | $45.03K | 223.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 33021 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 22826 | 7 |
View Market Depth
| Last trade - 12.47pm 02/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |